With the analysis among 6,174 patents, we discovered top 453 key players by total patent application. Genentech, Inc., Affibody AB, Ionis Pharmaceuticals, Inc. are dominant in this area. They take 9.36% of the total patent filing.
California, United States
Patent: 280
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 149
F. Hoffmann-La Roche Ltd.
Antwerpen, Belgium
Patent: 81
Hanmi Pharmaceutical Co., Ltd.
ProtAffin Biotechnologie AG
Steiermark, Austria
Patent: 76
Harpoon Therapeutics, Inc.
California, United States
Patent: 69
Xiangxue Life Science Technology (Guangdong) Co., Ltd.
Guangdong Sheng, China
Patent: 66
Eisai R&D Management Co., Ltd.
Tokyo-to, Japan
Patent: 64
With the analysis among 128 patents, we discovered top 29 start-ups by total patent application. Modalis Therapeutics Corp., GI Innovation, Inc., Navigo Proteins GmbH are active in this area.
Modalis Therapeutics Corp.
Tokyo-to, Japan
Patent: 14
Niedersachsen, Germany
Patent: 13
NOTTINGHAM, United Kingdom
Patent: 13
Just - Evotec Biologics, Inc.
Washington, United States
Patent: 7
Jiangsu Sheng, China
Patent: 6
Institut National de la Santé et de la Recherche Médicale
Lyvgen Biopharma Co., Ltd
Shanghai Shi, China
Patent: 6
California, United States
Patent: 6
Washington, United States
Patent: 6
With the analysis among related 1,561 patents applied in the last 5 years. We discover 375 most active companies in this area. The fast-growing Xiangxue Life Science Technology (Guangdong) Co., Ltd., Harpoon Therapeutics, Inc., Board of Trustees of the Leland Stanford Junior University take 8.65% of patent filing during this period.
Xiangxue Life Science Technology (Guangdong) Co., Ltd.
Guangdong Sheng, China
Patent: 57
Harpoon Therapeutics, Inc.
California, United States
Patent: 40
Board of Trustees of the Leland Stanford Junior University
California, United States
Patent: 38
Gyeonggi-do, South Korea
Patent: 34
Washington, United States
Patent: 30
Hanmi Pharmaceutical Co., Ltd.
F. Hoffmann-La Roche Ltd.
Eisai R&D Management Co., Ltd.
Tokyo-to, Japan
Patent: 28
Shanghai EpimAb Biotherapeutics Co. Ltd.
Shanghai Shi, China
Patent: 24
With the analysis among related 1,561 patents in last 5 years, we discover 227 new entrants. ABL Bio, Inc., Shanghai EpimAb Biotherapeutics Co. Ltd., Procter & Gamble Co. are the most active new entrants in this area.
Gyeonggi-do, South Korea
Patent: 34
Shanghai EpimAb Biotherapeutics Co. Ltd.
Shanghai Shi, China
Patent: 24
Ohio, United States
Patent: 17
Uttar Pradesh, India
Patent: 14
Modalis Therapeutics Corp.
Tokyo-to, Japan
Patent: 14
Eberhard Karls Universität Tübingen
Baden-Württemberg, Germany
Patent: 12
I-Mab Biopharma (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 12
Shanghai JMT Biological Technology Co Ltd
Shanghai Shi, China
Patent: 11
With the analysis among 1,797 patents, we discovered top 184 universities and scientific research institutions by total patent application. The Johns Hopkins University, The Scripps Research Institute, Osaka University are dominant in this area. They take 11.13% of the total patent filing.
The Johns Hopkins University
The Scripps Research Institute
California, United States
Patent: 48
Osaka-fu, Japan
Patent: 44
The Salk Institute for Biological Studies
California, United States
Patent: 43
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 39
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 32
North Carolina, United States
Patent: 31
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 31
Vlaams Instituut voor Biotechnologie - Flanders Institute
New York, United States
Patent: 23